- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma
Total 2584 results
-
Acerta Pharma BVAstraZenecaCompletedDiffuse Large B Cell Lymphoma | NHL | Non-hodgkin's Lymphoma | DLBCLUnited States, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsWithdrawnDiffuse Large B-Cell Lymphoma (DLBCL)
-
Molecular Templates, Inc.TerminatedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma | Non-hodgkin Lymphoma,B CellUnited States
-
Debiopharm International SACompletedDiffuse Large B-Cell Lymphoma | B-cell Non-Hodgkin's LymphomaUnited States, Czechia, Bulgaria, Belgium, Hungary, Ukraine, Italy, Poland, Switzerland
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Refractory Aggressive Non-Hodgkin LymphomaUnited States
-
Medical College of WisconsinMiltenyi Biomedicine GmbHActive, not recruitingB-cell Chronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
New York Medical CollegeRoswell Park Cancer InstituteRecruitingDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | CD20+ Lymphoblastic Lymphoma | Follicular Lymphoma, Grade IIIUnited States
-
Guangdong Ruishun Biotech Co., LtdRuijin Hospital; Southern Medical University, China; Beijing GoBroad HospitalNot yet recruitingB-cell Non-Hodgkin's Lymphoma
-
Swiss Group for Clinical Cancer ResearchRecruitingNon-hodgkin Lymphoma, B CellSwitzerland
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingNon-hodgkin Lymphoma,B CellChina
-
BioInvent International ABRecruitingIndolent B-Cell Non-Hodgkin LymphomaSpain, United States, Brazil, Sweden, Germany, Poland
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States
-
University of WashingtonJanssen PharmaceuticalsActive, not recruitingRecurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 PositiveUnited States
-
Gilead SciencesTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-hodgkin's Lymphoma | Small Lymphocytic LymphomaUnited States
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGNot yet recruiting
-
Seoul National University HospitalCompletedNon-hodgkin Lymphoma,B CellKorea, Republic of
-
Alopexx Oncology, LLCTerminatedB-cell Non-Hodgkin LymphomaUnited States
-
Alopexx Oncology, LLCTerminatedB-cell Non-Hodgkin LymphomaUnited States
-
Peking Union Medical College HospitalCellular Biomedicine Group Ltd.CompletedB-cell Non-Hodgkin LymphomaChina
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Chongqing Precision Biotech Co., LtdPeking University Cancer Hospital & InstituteRecruitingB Cell Lymphoma | Non Hodgkin LymphomaChina
-
SymBio PharmaceuticalsCompletedLow-grade B Cell Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not IndicatedJapan
-
A.O. Ospedale Papa Giovanni XXIIIActive, not recruitingIndolent Non-Hodgkin Lymphomas/Chronic Lymphocytic LeukemiaItaly
-
Gilead SciencesOno Pharmaceutical Co. LtdCompletedChronic Lymphocytic Leukaemia | Non Hodgkins LymphomaUnited Kingdom, France
-
Emory UniversityCelgene CorporationTerminatedB-Cell Lymphoma | Hodgkin's DiseaseUnited States
-
He HuangRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B-cell LymphomaChina
-
BioNova Pharmaceuticals (Shanghai) LTD.TerminatedFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaChina
-
Abramson Cancer Center of the University of PennsylvaniaCompletedFollicular Lymphomas | CD19+ Diffuse Large B-cell Lymphomas | Mantle Cell LymphomasUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.CompletedRelapse | Lymphomas Non-Hodgkin's B-CellChina
-
Sana BiotechnologyRecruitingNon Hodgkin's Lymphoma | Large B-cell LymphomaUnited States
-
Nanjing Yoko Biomedical Co., Ltd.CompletedB-Cell LymphomaChina
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | B-Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Prelude TherapeuticsBeiGeneRecruitingT-cell Lymphoma | Mantle Cell Lymphoma (MCL) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Syndrome | Aggressive B-Cell Non-Hodgkin's Lymphoma | Aggressive B-Cell NHLUnited States, Canada, Korea, Republic of, Australia, France, Poland, Italy, Germany, Switzerland, United Kingdom
-
Aptevo TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL) | Non-Hodgkin's Lymphoma (NHL)United States
-
Zhejiang DTRM BiopharmaCompletedChronic Lymphocytic Leukemia | B-cell LymphomasChina
-
University Hospital TuebingenHoffmann-La RocheCompletedPrimary Gastric Diffuse-Large B-Cell LymphomaGermany
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Central Nervous System Lymphoma | Mantle Cell Lymphoma (MCL) | Non Hodgkin Lymphoma (NHL)United States
-
Regeneron PharmaceuticalsAvailableDiffuse Large B-Cell Lymphoma (DLBCL) | Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | B-Cell Non-Hodgkin Lymphoma (NHL) | High-Grade B-Cell Lymphoma (HGBCL)
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingB-cell Non-Hodgkin's LymphomaChina
-
Shanghai Henlius BiotechCompleted
-
Shanghai Henlius BiotechCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Transformed Non-Hodgkin LymphomaUnited States